Investor Presentation First Nine Months of 2022

121 Investor presentation First nine months of 2022 Diabetes market share and market growth in Region China 50% 40% 30% 20% 10% Diabetes market growth and Novo Nordisk market share Diabetes market size and growth DKK billion 50% ~13% 1 1 25 40% 33% 30% 20% 13% 11% 10% 33% ~11% Region China 2 28 33% 0% 0% Aug NN market share Aug Aug Novo Nordisk AZ Others 2019 -Market growth (right axis) 2022 2021 Aug 2022 Novo Nordisk Competitors -NN growth (right axis) Source: IQVIA, Aug 2022, Value, MAT, NN: Novo Nordisk Region China covers Mainland China, Taiwan, and Hong Kong

View entire presentation